Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06551116
- Conditions
- HER2-Positive Metastatic Breast Cancer
- Locations
-
- University of California San Francisco Medical Center San Francisco, California, United States
- Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
- Smilow Cancer Hospital Care Center Fairfield, Connecticut, United States
- Smilow Cancer Hospital at Glastonbury Glastonbury, Connecticut, United States
NCT06625775
- Conditions
- Advanced Breast Cancer, Advanced Lung Cancer, Breast Diseases, +35 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Los Angeles Los Angeles, California, United States
- University of California San Diego Moores Cancer Center San Diego, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
NCT05959291
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-Positive Metastatic Breast Cancer, +5 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT05868226
- Conditions
- Breast Diseases, Breast Neoplasms, ER Positive Breast Cancer, +29 more
- Locations
-
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- Moffitt Cancer Center Tampa, Florida, United States
- The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
NCT04319757
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
- Locations
-
- Northwestern Univeristy Chicago, Illinois, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Taipei Veteran General Hospital Taipei, Taiwan
NCT02605915
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-Positive Metastatic Breast Cancer, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences; Winthrop Rockefeller Cancer Institute Little Rock, Arkansas, United States
- Joliet oncology hematology associates Joliet, Illinois, United States
- Horizon Oncology Research, Inc. Lafayette, Indiana, United States
Active, Not Recruiting
Testing a New Imaging Agent to Identify Cancer
NCT04692831
- Conditions
- HER-2 Positive Malignant Carcinoma of Breast, HER-2 Protein Overexpression, HER2-Positive Metastatic Breast Cancer
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) Commack, New York, United States
Active, Not Recruiting
Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
NCT03417544
- Conditions
- Central Nervous System Metastases, HER2-Positive Metastatic Breast Cancer
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
NCT05230810
- Conditions
- HER2-Positive Metastatic Breast Cancer
- Locations
-
- University of Colorado Cancer Center Aurora, Colorado, United States
- Cancer Care & Hematology-Fort Collins Fort Collins, Colorado, United States
- Louisiana State University Health Sciences Center New Orleans, Louisiana, United States
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
Active, Not Recruiting
Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
NCT06714617
- Conditions
- Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
- Locations
-
- SCRI-Denver HealthOne Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
- SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
- Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
Active, Not Recruiting
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
NCT05036252
- Conditions
- Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, +19 more
- Locations
-
- Memorial Sloan - Kettering Cancer Center New York, United States
Active, Not Recruiting
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- University of Colorado - Anschutz Medical Campus - PPDS Aurora, Colorado, United States
- Advent Health Orlando Orlando, Florida, United States
- BRCR Medical Center Inc Plantation, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States